dn 1417 has been researched along with bucladesine in 1 studies
Studies (dn 1417) | Trials (dn 1417) | Recent Studies (post-2010) (dn 1417) | Studies (bucladesine) | Trials (bucladesine) | Recent Studies (post-2010) (bucladesine) |
---|---|---|---|---|---|
94 | 2 | 0 | 9,775 | 13 | 210 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagai, Y; Nagawa, Y; Narumi, S; Saji, Y | 1 |
1 other study(ies) available for dn 1417 and bucladesine
Article | Year |
---|---|
Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in oxygen consumption and cyclic AMP formation of rat cerebral cortex slices.
Topics: Animals; Bucladesine; Carbachol; Cerebral Cortex; Cyclic AMP; Dopamine; Drug Interactions; Hormones; In Vitro Techniques; Kinetics; Male; Norepinephrine; Oxygen Consumption; Pentobarbital; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1984 |